Sign in
4

Changes in Ownership

FENNEC PHARMACEUTICALS INC. Filed Acc 0002043395-26-000004

Chief Medical Officer acquired 168 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Sayad Pierre Sargis Chief Medical Officer 2026-04-30 Option exercise +168 20,847 D
Loading xslF345X06/form4-05012026_040509.xml…